CVS Health Co. (NYSE:CVS - Get Free Report)'s share price gapped down before the market opened on Thursday . The stock had previously closed at $45.28, but opened at $44.29. CVS Health shares last traded at $44.53, with a volume of 1,682,907 shares traded.
Analysts Set New Price Targets
A number of research firms recently weighed in on CVS. UBS Group increased their price target on CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a research report on Thursday, November 7th. Mizuho dropped their target price on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating on the stock in a research report on Thursday, October 24th. Cantor Fitzgerald restated a "neutral" rating and set a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. Piper Sandler lowered their price objective on shares of CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research report on Monday, November 25th. Finally, Royal Bank of Canada decreased their target price on CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research report on Friday, November 15th. One analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $70.50.
Get Our Latest Research Report on CVS
CVS Health Stock Down 3.3 %
The business's fifty day moving average price is $57.14 and its two-hundred day moving average price is $58.44. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The firm has a market cap of $55.09 billion, a P/E ratio of 11.11, a P/E/G ratio of 0.89 and a beta of 0.54.
CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. During the same quarter in the prior year, the business earned $2.21 earnings per share. The company's revenue was up 6.3% on a year-over-year basis. As a group, equities research analysts anticipate that CVS Health Co. will post 5.32 EPS for the current year.
Institutional Investors Weigh In On CVS Health
Hedge funds have recently bought and sold shares of the company. &PARTNERS boosted its position in shares of CVS Health by 177.6% in the second quarter. &PARTNERS now owns 14,960 shares of the pharmacy operator's stock valued at $884,000 after acquiring an additional 9,571 shares during the period. JB Capital LLC grew its position in CVS Health by 3.1% in the 2nd quarter. JB Capital LLC now owns 11,273 shares of the pharmacy operator's stock worth $666,000 after purchasing an additional 335 shares during the last quarter. Diversified LLC bought a new position in shares of CVS Health during the 2nd quarter worth about $212,000. Horizon Bancorp Inc. IN raised its position in shares of CVS Health by 16.1% during the second quarter. Horizon Bancorp Inc. IN now owns 3,424 shares of the pharmacy operator's stock valued at $202,000 after buying an additional 476 shares during the last quarter. Finally, Keynote Financial Services LLC lifted its stake in shares of CVS Health by 4.9% in the second quarter. Keynote Financial Services LLC now owns 25,031 shares of the pharmacy operator's stock valued at $1,478,000 after buying an additional 1,168 shares during the period. 80.66% of the stock is currently owned by institutional investors.
CVS Health Company Profile
(
Get Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
